Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Abrocitinib may effectively treat stubborn alopecia universalis.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

65% TCA improves acne scars more but has more side effects than 50% GA.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

PRP treatment may help with alopecia areata, especially in newer cases.

Topical immunotherapy with SADBE and DPCP is most effective for short-term hair regrowth in children with severe alopecia areata.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

The treatment was ineffective in humans.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.